chr5-176621218-G-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 1P and 5B. PP5BP4BS2
The NM_003085.5(SNCB):c.368C>A(p.Pro123His) variant causes a missense change. The variant allele was found at a frequency of 0.000281 in 1,612,146 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00029 ( 0 hom. )
Consequence
SNCB
NM_003085.5 missense
NM_003085.5 missense
Scores
11
8
Clinical Significance
Conservation
PhyloP100: 4.55
Genes affected
SNCB (HGNC:11140): (synuclein beta) This gene encodes a member of a small family of proteins that inhibit phospholipase D2 and may function in neuronal plasticity. The encoded protein is abundant in lesions of patients with Alzheimer disease. A mutation in this gene was found in individuals with dementia with Lewy bodies. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
PP5
Variant 5-176621218-G-T is Pathogenic according to our data. Variant chr5-176621218-G-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 7026.We mark this variant Likely_pathogenic, oryginal submissions are: {Likely_pathogenic=1, not_provided=1, Uncertain_significance=1}.
BP4
Computational evidence support a benign effect (MetaRNN=0.22367951). . Strength limited to SUPPORTING due to the PP5.
BS2
High AC in GnomAd4 at 31 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SNCB | NM_003085.5 | c.368C>A | p.Pro123His | missense_variant | 5/6 | ENST00000393693.7 | NP_003076.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SNCB | ENST00000393693.7 | c.368C>A | p.Pro123His | missense_variant | 5/6 | 1 | NM_003085.5 | ENSP00000377296 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000204 AC: 31AN: 152154Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
31
AN:
152154
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000169 AC: 42AN: 248540Hom.: 0 AF XY: 0.000164 AC XY: 22AN XY: 134428
GnomAD3 exomes
AF:
AC:
42
AN:
248540
Hom.:
AF XY:
AC XY:
22
AN XY:
134428
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000289 AC: 422AN: 1459874Hom.: 0 Cov.: 32 AF XY: 0.000295 AC XY: 214AN XY: 726130
GnomAD4 exome
AF:
AC:
422
AN:
1459874
Hom.:
Cov.:
32
AF XY:
AC XY:
214
AN XY:
726130
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000204 AC: 31AN: 152272Hom.: 0 Cov.: 32 AF XY: 0.000188 AC XY: 14AN XY: 74452
GnomAD4 genome
AF:
AC:
31
AN:
152272
Hom.:
Cov.:
32
AF XY:
AC XY:
14
AN XY:
74452
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
2
ALSPAC
AF:
AC:
1
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
2
ExAC
AF:
AC:
25
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:3Uncertain:1Other:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Lewy body dementia Pathogenic:2Other:1
Likely pathogenic, criteria provided, single submitter | clinical testing | DASA | Feb 05, 2022 | The c.368C>A;p.(Pro123His) missense variant has been observed in affected individual(s) and ClinVar contains an entry for this variant (Clinvar ID: 7026; OMIM: 602569.0002; PMID: 15365127) - PS4_supporting. Well-established in vitro or in vivo functional studies supportive of a damaging effect on the gene or gene product (PMID: 21045828) - PS3. The variant is located in a mutational hot spot and/or critical and well-established functional domain (Synuclein) - PM1. The variant is present at low allele frequencies population databases (rs104893937 – gnomAD 0.002037%; ABraOM no frequency - http://abraom.ib.usp.br/) - PM2_supporting. and allele frequency is greater than expected for disorder - BS1. In summary, the currently available evidence indicates that the variant is likely pathogenic. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Sep 14, 2004 | - - |
not provided, no classification provided | phenotyping only | GenomeConnect - Brain Gene Registry | - | Variant interpreted as Likely pathogenic and reported on 01-14-2020 by Lab PreventionGenetics. Assertions are reported exactly as they appear on the patient provided laboratory report. GenomeConnect does not attempt to reinterpret the variant. The IDDRC-CTSA National Brain Gene Registry (BGR) is a study funded by the U.S. National Center for Advancing Translational Sciences (NCATS) and includes 13 Intellectual and Developmental Disability Research Center (IDDRC) institutions. The study is led by Principal Investigator Dr. Philip Payne from Washington University. The BGR is a data commons of gene variants paired with subject clinical information. This database helps scientists learn more about genetic changes and their impact on the brain and behavior. Participation in the Brain Gene Registry requires participation in GenomeConnect. More information about the Brain Gene Registry can be found on the study website - https://braingeneregistry.wustl.edu/. - |
SNCB-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 13, 2024 | The SNCB c.368C>A variant is predicted to result in the amino acid substitution p.Pro123His. This variant was reported in individuals with dementia with Lewy bodies (Ohtake et al. 2004. PubMed ID: 15365127, family study). A functional study showed that transgenic mice expressing this variant developed progressive neurodegeneration (Fujita et al. 2010. Pubmed ID: 21045828). Other studies elaborated on the mechanism of this variant (Janowska et al 2015. PubMed ID: 26332674; Psol et al. 2021. PubMed ID: 33760043). However, family segregation study shows that this variant does not produce a disease phenotype in all individuals suggesting reduced penetrance for this variant (Ohtake et al. 2004. PubMed ID: 15365127). This variant is reported in 0.036% of alleles in individuals of European (non-Finnish) descent in gnomAD. This variant is interpreted as pathogenic. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | AiLife Diagnostics, AiLife Diagnostics | Mar 29, 2022 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Benign
DEOGEN2
Uncertain
D;T;D;D;D
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;D;.;.;T
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T;T;T
MetaSVM
Uncertain
D
MutationAssessor
Benign
L;.;L;L;L
MutationTaster
Benign
A;A;A;A
PrimateAI
Benign
T
PROVEAN
Benign
N;.;N;N;N
REVEL
Uncertain
Sift
Uncertain
D;.;D;D;D
Sift4G
Uncertain
D;D;D;D;D
Polyphen
D;.;D;D;D
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at